Search - tctmd.com

Displaying 461 - 480 of 669

Sort: Relevancy | Date

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

Presenter: Francesco Prati, Renu Virmani, Antonio Colombo

October 31, 2017

Presentation TCT 2017

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Presenter: Francesco Prati, Renu Virmani, Abraham Tzafriri, MD

October 31, 2017

Presentation TCT 2017

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

Presenter: D. Christopher Metzger, Ido Weinberg

October 31, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois

October 30, 2017

Presentation TCT 2017

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter

October 30, 2017

Presentation TCT 2017

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Issam D. Moussa, Manesh R. Patel

October 30, 2017

Presentation TCT 2017

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Issam D. Moussa, Alfredo R. Galassi

October 30, 2017

Presentation TCT 2017

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari

October 30, 2017

Presentation TCT 2017

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber

October 30, 2017

Advertisement

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content